An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease
NCT02537626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2021-05-25
Summary
This study evaluates the effect of applying low level laser light therapy to individuals with mild to moderate Alzheimer's disease to see if it may improve their memory, thinking and behaviors. Half of the participants will receive the real treatment with the laser device and the other half of the participants will receive a placebo treatment (not active laser).
Conditions
Interventions
- DEVICE
-
Erchonia ALS Laser
The Erchonia ALS Laser is administered to the subject's frontal cortex, temporal regions and base of the skull 8 times across 4 consecutive weeks, 2 times each week, for 10 minutes of treatment time per administration. The total energy delivered to the subject per procedure administration is 22.5 joules.
- DEVICE
-
Placebo Laser
The Placebo Laser is administered to the subject's frontal cortex, temporal regions and base of the skull 8 times across 4 consecutive weeks, 2 times each week, for 10 minutes of treatment time per administration. There is no energy delivered to the subject.
Sponsors & Collaborators
-
Erchonia Corporation
lead INDUSTRY
Principal Investigators
-
Leon Morales-Quezada, MD · Neocemod
-
Andrew Campbell, MD · Pruebas Clinicas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-15
- Primary Completion
- 2020-06-15
- Completion
- 2020-10-15
Countries
- Mexico
Study Locations
More Related Trials
-
Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease
NCT02359864 ·Status: TERMINATED ·Phase: NA
-
Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
NCT00594568 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
NCT02955706 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
NCT01195389 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a Biophoton Therapy on Patients With Brain Disorders
NCT06147999 ·Status: RECRUITING ·Phase: NA
-
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
NCT02600130 ·Status: COMPLETED ·Phase: PHASE1
-
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
NCT05904132 ·Status: RECRUITING ·Phase: NA
-
A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
NCT05413655 ·Status: RECRUITING ·Phase: PHASE2
-
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
NCT03933696 ·Status: COMPLETED ·Phase: NA
-
Open-label Extension Study in Participants With Early Alzheimer's Disease
NCT07105709 ·Status: RECRUITING ·Phase: PHASE2
-
A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI
NCT07287852 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
The Clinical Trial of Low Dose Irradiation for Alzheimer's Disease
NCT05635968 ·Status: COMPLETED ·Phase: PHASE2
-
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NCT04055376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Language and Memory in Patients With Alzheimer's Disease
NCT00593372 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease
NCT07205601 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sirtuin-NAD Activator in Alzheimer's Disease
NCT05040321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3
-
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
NCT03721705 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
NCT01636596 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
NCT01600859 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
NCT03056729 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
NCT02957682 ·Status: COMPLETED ·Phase: PHASE4
-
Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease
NCT02833792 ·Status: UNKNOWN ·Phase: PHASE2